Skip to main content

Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis.

Publication ,  Journal Article
Khan, MS; Fonarow, GC; Ahmed, A; Greene, SJ; Vaduganathan, M; Khan, H; Marti, C; Gheorghiade, M; Butler, J
Published in: Circ Heart Fail
August 2017

BACKGROUND: The association between angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) doses on outcomes in patients with heart failure (HF) with reduced ejection fraction is uncertain. The objective of this study was to investigate the effect of dose of ACEI and ARBs on outcomes and drug discontinuation in patients with HF with reduced ejection fraction. METHODS AND RESULTS: MEDLINE, Ovid SP, and Embase were searched from the inception of these databases till August 2016. Randomized controlled trials that compared high doses of ACEI or ARB against low doses among patients with HF with reduced ejection fraction were included. Pooled analysis was done using a random-effects model, and quality of the studies was assessed by JADAD scale. The main outcomes were all-cause mortality and drug discontinuation. A total of 6 studies (4841 patients in low-dose and 4330 patients in high-dose groups) were included. Compared with low dose, high-dose ACEI or ARBs decreased all-cause mortality modestly (relative risk, 0.94; 95% confidence interval (CI), 0.89-1.00; P=0.05; I2=0%) and composite of HF hospitalizations and all-cause mortality (relative risk, 0.93; 95% CI, 0.87-1.00; P=0.04; I2=39.8%). No significant difference was found between the 2 groups in HF hospitalizations (relative risk, 0.94; 95% CI, 0.70-1.26; P=0.68; I2=52.8%) and all-cause hospitalizations (relative risk, 0.97; 95% CI, 0.85-1.11; P=0.67; I2=31.7%) risk. Discontinuation rates were also not significantly different in both groups (odds ratio, 1.13; 95% CI, 0.92-1.39; P=0.25; I2=32.6%). CONCLUSIONS: In patients with HF with reduced ejection fraction, compared with lower doses, higher doses of ACEI and ARB significantly though modestly improved the composite end point of all-cause mortality or HF hospitalization without significantly increasing the chances of discontinuation.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circ Heart Fail

DOI

EISSN

1941-3297

Publication Date

August 2017

Volume

10

Issue

8

Location

United States

Related Subject Headings

  • Ventricular Function, Left
  • Treatment Outcome
  • Time Factors
  • Stroke Volume
  • Risk Factors
  • Risk Assessment
  • Renin-Angiotensin System
  • Randomized Controlled Trials as Topic
  • Odds Ratio
  • Middle Aged
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Khan, M. S., Fonarow, G. C., Ahmed, A., Greene, S. J., Vaduganathan, M., Khan, H., … Butler, J. (2017). Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis. Circ Heart Fail, 10(8). https://doi.org/10.1161/CIRCHEARTFAILURE.117.003956
Khan, Muhammad Shahzeb, Gregg C. Fonarow, Ali Ahmed, Stephen J. Greene, Muthiah Vaduganathan, Hassan Khan, Catherine Marti, Mihai Gheorghiade, and Javed Butler. “Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis.Circ Heart Fail 10, no. 8 (August 2017). https://doi.org/10.1161/CIRCHEARTFAILURE.117.003956.
Khan MS, Fonarow GC, Ahmed A, Greene SJ, Vaduganathan M, Khan H, et al. Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis. Circ Heart Fail. 2017 Aug;10(8).
Khan, Muhammad Shahzeb, et al. “Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis.Circ Heart Fail, vol. 10, no. 8, Aug. 2017. Pubmed, doi:10.1161/CIRCHEARTFAILURE.117.003956.
Khan MS, Fonarow GC, Ahmed A, Greene SJ, Vaduganathan M, Khan H, Marti C, Gheorghiade M, Butler J. Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis. Circ Heart Fail. 2017 Aug;10(8).

Published In

Circ Heart Fail

DOI

EISSN

1941-3297

Publication Date

August 2017

Volume

10

Issue

8

Location

United States

Related Subject Headings

  • Ventricular Function, Left
  • Treatment Outcome
  • Time Factors
  • Stroke Volume
  • Risk Factors
  • Risk Assessment
  • Renin-Angiotensin System
  • Randomized Controlled Trials as Topic
  • Odds Ratio
  • Middle Aged